Skip to main content

Day: November 27, 2024

Company announcement no 20/2024 October 2024 Sales price

October 2024 Sales price Group sales prices development as followsQ1           2017       1,24 EUR/kg live weight (Jan 1,23 EUR – Feb 1,24 EUR – Marts 1,26 EUR) Q2           2017       1,41 EUR/kg live weight (Apr 1,43 EUR – May 1,41 EUR – June 1,39 EUR) Q3           2017       1,30 EUR/kg live weight (July 1,32 EUR – Aug 1,30 EUR – Sept 1,29 EUR) Q4           2017       1,13 EUR/kg live weight (Oct 1,17 EUR – Nov 1,12 EUR – Dec 1,11 EUR) Q1           2018       1,09 EUR/kg live weight (Jan 1,07 EUR – Feb 1,08 EUR – Marts 1,12 EUR) Q2           2018       1,17 EUR/kg live weight (April 1,18 EUR – May 1,15 EUR – June 1,18 EUR) Q3           2018       1,19 EUR/kg live weight (July 1,19 EUR, August 1,18 EUR, September 1,19) Q4           2018       1,10 EUR/kg live weight (Oct 1,11 EUR – Nov 1,12...

Continue reading

IDEX Biometrics ASA: Mandatory notification of trade by primary insider – 27 Nov 2024

Kristian Flaten, CFO in IDEX Biometrics ASA, has today bought 1,000,000 shares in IDEX Biometrics ASA, at an average price of NOK 0.1180 per share. After this transaction, Flaten owns 1,000,000 shares in IDEX Biometrics ASA. Please refer to the attached notification of trading for further details. For further information contact:Marianne Bøe, Head of Investor RelationsKristian Flaten, CFOE-mail: ir@idexbiometrics.comTel: + 47 67 83 91 19 About IDEX BiometricsIDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric...

Continue reading

Ocugen CEO to Present at NobleCon20 – Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference

MALVERN, Pa., Nov. 27, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies, biologics, and vaccines, today announced that Dr. Shankar Musunuri, Chairman, CEO, and Co-Founder of Ocugen will present at NobleCon20 – Noble Capital Markets’ 20th Annual Emerging Growth Equity Conference at Florida Atlantic University, Executive Education Complex, in Boca Raton, FL—taking place December 3 – 4, 2024. “Every year, NobleCon showcases emerging growth companies from a variety of industries to a relevant investor audience,” said Dr. Musunuri. “I look forward to sharing an update on our clinical programs for attendees who may not yet be familiar with the Ocugen story.” Details regarding the presentation...

Continue reading

NurExone Reports Third Quarter 2024 Financial Results and Provides Corporate Update

TORONTO and HAIFA, Israel, Nov. 27, 2024 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company developing regenerative medicine therapies, is pleased to announce its financial and operational results for the three and nine months ended September 30, 2024, the highlights of which are included in this news release. The Company’s complete set of condensed interim consolidated financial statements for the three and nine months ended September 30, 2024, and accompanying management’s discussion and analysis for the period can be accessed by visiting the Company’s website at www.nurexone.com and its profile page on SEDAR+ at www.sedarplus.ca. Key Business HighlightsIn July 2024 and September 2024, the Company generated gross proceeds...

Continue reading

Goodfood Reports Fiscal Year and Fourth Quarter 2024 Results with Net sales of $153 million and $34 million, Gross Profit of $63 million and $13 million and Adjusted EBITDA¹ of $9 million and $0.5 million, respectively

Record annual results in key profitability metrics with gross margin2 of 41.2%, an improvement of 2.4% compared to last fiscal year and adjusted free cash flow1 of $8 million, an improvement of 12 million compared to the same period last year Net sales of $34 million in the fourth quarter of 2024, with gross profit of $13 million and gross margin2 of 38.1% Net loss of $3 million, adjusted EBITDA margin1 of 1% and adjusted EBITDA1 of $0.5 million in the fourth quarter of 2024 Cash flows used in operating activities of $1 million and adjusted free cash flow1 was negative $1 million for the fourth quarter of 2024, with an ending cash balance at $24 million, only slightly down compared to last year, driven primarily by debt reduction, with total net debt to adjusted EBITDA1 at 2.49 compared to 4.44 last year The recently announced Genuine...

Continue reading

BOS Reports Financial Results for the Third Quarter of the Year 2024

RISHON LE ZION, Israel, Nov. 27, 2024 (GLOBE NEWSWIRE) — BOS Better Online Solutions Ltd. (“BOS” or the “Company”) (NASDAQ: BOSC) a global integrator for supply chain technologies, reported its financial results for the third quarter of the year 2024. Third Quarter 2024 Statements of Operations Highlights:Revenues for the third quarter amounted to $9.83 million, roughly unchanged from the comparable quarter last year. Gross profit margin for the third quarter of 2024 increased to 21.9% compared to 20.9% in the comparable quarter last year. Operating profit for the third quarter of 2024 increased by 24.8% to $551,000 from $441,000 in the comparable quarter last year. EBITDA for the third quarter of 2024 increased by 18.3% to $710,000 compared to $600,000 in the comparable quarter last year. Financial income...

Continue reading

Sales growth continued in Q3 2024 with solid profitability

Report on the first nine months of 2024for ROCKWOOL A/SRelease no. 63 – 2024to Nasdaq Copenhagen 27 November 2024 Sales growth continued in Q3 2024 with solid profitability HighlightsSales in the first nine months of 2024 reached 2885 MEUR, an increase of seven percent measured in both local currencies and reported figures compared to last year, driven by volume growth; sales prices overall remained stableQ3 2024 sales reached 957 MEUR, an increase of five percent in local currencies and six percent in reported figures compared to last year.EBITDA in the first nine months of 2024 reached 710 MEUR, up 23 percent, yielding a 24.6 percent EBITDA margin. Earnings continued at a good level, as sales prices overall remained stable, and productivity improved.EBITDA in Q3 2024 reached 241 MEUR, an increase of 10 percent compared to last...

Continue reading

QuantaSing Announces Unaudited Financial Results for the First Quarter of Fiscal Year 2025

BEIJING, Nov. 27, 2024 (GLOBE NEWSWIRE) — QuantaSing Group Limited (NASDAQ: QSG) (“QuantaSing” or the “Company”), a leading lifestyle solution provider empowering adults to live better and longer, today announced its unaudited financial results for the first quarter of the fiscal year ending June 30, 2025 (the “first quarter of FY 2025”, which refers to the quarter from July 1, 2024 to September 30, 2024). Highlights for the First Quarter of FY 2025Revenues for the first quarter of FY 2025 were RMB810.4 million (US$115.5 million), representing a decrease of 19.0% from the fourth quarter of the fiscal year ended June 30, 2024 (the “fourth quarter of FY 2024”) and a decrease of 6.8% from the first quarter of the fiscal year ended June 30, 2024 (the “first quarter of FY 2024”). Gross billings of individual online learning services1...

Continue reading

Skyquest Technology Consulting Signs Landmark MoU with Ministry of Water, Ethiopia at COP29

Skyquest Technology Consulting Private Limited is thrilled to announce the signing of a groundbreaking Memorandum of Understanding (MoU) with the Ministry of Water, Ethiopia. This strategic partnership, introduced at the prestigious COP29 conference, is set to revolutionize water security and management practices in Ethiopia, marking a significant milestone in the global effort to address water-related challenges. Ahmedabad, India, Nov. 27, 2024 (GLOBE NEWSWIRE) — At COP29, Skyquest unveiled its SUSTECH initiative (www.sustech.earth), which focuses on five key areas: critical infrastructure, clean water, one health, food security, and clean air. Under the clean water initiative, this MoU was signed to address critical issues in Ethiopia’s water sector, underscoring the global commitment to sustainable development. The MoU,...

Continue reading

Ipsos: Monthly declaration of shares and voting rights – October 2024

November 27, 2024 MONTHLY DISCLOSURE OF THE TOTAL NUMBER OF SHARES AND VOTING RIGHTS Articles L. 233-8 II of the Commercial Code and 223-16 of the General Regulation of the AMFDate   Shares   Voting rightsTheoretical* Exercisable**31 October 2024 43,203,225 48,761,517 48,634,536*This number is calculated on the basis of all the shares to which voting rights are attached, including shares which voting rights have been suspended, in accordance with Article 223-11 of the AMF general regulation related to the calculation of the crossing of thresholds with regard to the number of voting rights. **For information purposes, this number excludes the shares which voting rights have been suspended. The information is also available in the « Regulated Information » section of the Ipsos website: https://www.ipsos.com/en/regulated-informations/en....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.